Breast cancer surgery in the era of genetic uncertainty: real-world outcomes in BRCA1/2 pathogenic variants and variants of uncertain significance
Abstract Background Germline testing for BRCA1 and BRCA2 has become integral to the management of breast cancer, with pathogenic variants strongly influencing surgical decision-making. However, the increasing detection of variants of uncertain significance (VUS) presents a major clinical challenge,...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2026-02-01
|
| Serie: | BMC Cancer |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s12885-026-15721-z |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
